Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke

Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a fear among practitioner...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruce, Nhu T., Neil, William P., Zivin, Justin A.
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Cerebrovascular Disease and Stroke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085754/
https://www.ncbi.nlm.nih.gov/pubmed/21424751
http://dx.doi.org/10.1007/s11936-011-0122-0
_version_ 1782202652470280192
author Bruce, Nhu T.
Neil, William P.
Zivin, Justin A.
author_facet Bruce, Nhu T.
Neil, William P.
Zivin, Justin A.
author_sort Bruce, Nhu T.
collection PubMed
description Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a fear among practitioners of legal repercussions as a result of an increased risk of intracerebral hemorrhage due to tPA. This review of legal cases involving tPA will show that instead, physicians are often found liable as a result of not treating with tPA.
format Text
id pubmed-3085754
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-30857542011-06-06 Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke Bruce, Nhu T. Neil, William P. Zivin, Justin A. Curr Treat Options Cardiovasc Med Cerebrovascular Disease and Stroke Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a fear among practitioners of legal repercussions as a result of an increased risk of intracerebral hemorrhage due to tPA. This review of legal cases involving tPA will show that instead, physicians are often found liable as a result of not treating with tPA. Current Science Inc. 2011-03-22 2011 /pmc/articles/PMC3085754/ /pubmed/21424751 http://dx.doi.org/10.1007/s11936-011-0122-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Cerebrovascular Disease and Stroke
Bruce, Nhu T.
Neil, William P.
Zivin, Justin A.
Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
title Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
title_full Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
title_fullStr Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
title_full_unstemmed Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
title_short Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
title_sort medico-legal aspects of using tissue plasminogen activator in acute ischemic stroke
topic Cerebrovascular Disease and Stroke
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085754/
https://www.ncbi.nlm.nih.gov/pubmed/21424751
http://dx.doi.org/10.1007/s11936-011-0122-0
work_keys_str_mv AT brucenhut medicolegalaspectsofusingtissueplasminogenactivatorinacuteischemicstroke
AT neilwilliamp medicolegalaspectsofusingtissueplasminogenactivatorinacuteischemicstroke
AT zivinjustina medicolegalaspectsofusingtissueplasminogenactivatorinacuteischemicstroke

Ejemplares similares